Manmeet Singh Soni — Chief Financial Officer at Alnylam Pharmaceuticals

Mr. Manmeet Singh Soni has been Chief Financial Officer of Alnylam Pharmaceuticals, Inc. since May 09, 2017. Mr. Soni has been an Executive at Ariad Pharmaceuticals, Inc. since February 16, 2017. He served as the Chief Financial Officer, Executive Vice President and Treasurer at Ariad Pharmaceuticals, Inc. from March 21, 2016 to February 16, 2017. Mr. Soni served as the Chief Financial Officer of Pharmacyclics Inc. since February 4, 2014 and served as its Principal Accounting Officer from August 2013 to February 2014. Mr. Soni served as Treasurer of Pharmacyclics Inc. since August 16, 2013. He served as Senior Vice President of Finance at Pharmacyclics Inc. since August 2013, served as its Principal Financial Officer and Principal Accounting Officer since August 16, 2013. Mr. Soni served as Vice President and Corporate Controller at Pharmacyclics Inc. since February 2013 and Executive Vice President of finance until February 4, 2014. Previously, he worked at ZELTIQ Aesthetics where he served as controller and Senior Director of finance and where he was responsible for accounting, SEC and Treasury functions. He worked at PricewaterhouseCoopers San Jose, in the Life Science and Venture Capital Group, providing audit and assurance services to various public and privately held companies in the pharmaceutical, biotechnology, software and semiconductor space. He serves as Director of Genoscience Pharma. He has been an Independent Director of Pulse Biosciences, Inc. since November 2, 2017. He graduated from Hansraj College at Delhi University in India. He is a Certified Public Accountant, licensed in the state of California and a Chartered Accountant from India.